We found that CSF-1R+ carcinoma cells are associated with significantly adverse outcome in patients with ER-positive status (HR 1.82, 95% CI 1.30–2.54; p < 0.001) but not in those with ER-negative status (HR 1.08, 95% CI 0.73–1.60; p = 0.71) (Figure 3C,D). The gene discussed is CSF1R; the disease is carcinoma.